Inicio>>Signaling Pathways>> Microbiology & Virology>> RSV>>Sisunatovir hydrochloride

Sisunatovir hydrochloride (Synonyms: RV521 hydrochloride)

Catalog No.GC62217

El clorhidrato de sisunatovir (RV521), un inhibidor de la proteÍna de fusiÓn RSV (RSV-F) disponible por vÍa oral, muestra una potente eficacia contra un panel de aislados clÍnicos de virus RSV-A y RSV-B, con IC50 de 1,4nM y 1,0nM, respectivamente .

Products are for research use only. Not for human use. We do not sell to patients.

Sisunatovir hydrochloride Chemical Structure

Cas No.: 1903763-83-6

Tamaño Precio Disponibilidad Cantidad
10mM (in 1mL DMSO)
111,00 $
Disponible
1mg
35,00 $
Disponible
5mg
105,00 $
Disponible
10mg
175,00 $
Disponible
25mg
315,00 $
Disponible
50mg
525,00 $
Disponible
100mg
805,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Sisunatovir (RV521) hydrochloride, an orally available inhibitor of the RSV fusion (RSV-F) protein, exhibits potent efficacy against a panel of clinical isolates of RSV-A and RSV-B viruses, with IC50s of 1.4 nM and 1.0 nM, respectively[1].

[1]. DeVincenzo J, et al. A Randomized, Placebo-Controlled, Respiratory Syncytial Virus Human Challenge Study of the Antiviral Efficacy, Safety, and Pharmacokinetics of RV521, an Inhibitor of the RSV-F Protein. Antimicrob Agents Chemother. 2020;64(2):e01884-19. Published 2020 Jan 27.

Reseñas

Review for Sisunatovir hydrochloride

Average Rating: 5 ★★★★★ (Based on Reviews and 22 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Sisunatovir hydrochloride

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.